North Capital Inc. Cuts Holdings in CVS Health Corporation $CVS

North Capital Inc. lowered its holdings in shares of CVS Health Corporation (NYSE:CVS) by 50.1% during the second quarter, HoldingsChannel.com reports. The firm owned 1,594 shares of the pharmacy operator’s stock after selling 1,600 shares during the period. North Capital Inc.’s holdings in CVS Health were worth $110,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in CVS. Hazlett Burt & Watson Inc. raised its position in shares of CVS Health by 10.9% during the 2nd quarter. Hazlett Burt & Watson Inc. now owns 1,682 shares of the pharmacy operator’s stock worth $117,000 after purchasing an additional 165 shares during the last quarter. Williams Financial LLC increased its stake in CVS Health by 2.5% during the 2nd quarter. Williams Financial LLC now owns 6,923 shares of the pharmacy operator’s stock worth $478,000 after buying an additional 167 shares in the last quarter. Hemington Wealth Management raised its holdings in shares of CVS Health by 33.7% during the first quarter. Hemington Wealth Management now owns 682 shares of the pharmacy operator’s stock valued at $46,000 after acquiring an additional 172 shares during the last quarter. Sumitomo Life Insurance Co. boosted its stake in shares of CVS Health by 1.0% in the first quarter. Sumitomo Life Insurance Co. now owns 17,114 shares of the pharmacy operator’s stock worth $1,159,000 after acquiring an additional 174 shares during the last quarter. Finally, GW&K Investment Management LLC increased its position in shares of CVS Health by 39.4% during the first quarter. GW&K Investment Management LLC now owns 637 shares of the pharmacy operator’s stock worth $43,000 after purchasing an additional 180 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Stock Up 0.3%

CVS opened at $78.80 on Friday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.62 and a current ratio of 0.83. The business’s fifty day moving average is $77.04 and its two-hundred day moving average is $69.33. CVS Health Corporation has a one year low of $43.56 and a one year high of $85.15. The company has a market cap of $100.03 billion, a price-to-earnings ratio of 207.37, a PEG ratio of 0.87 and a beta of 0.60.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.24. The firm had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, November 3rd. Investors of record on Thursday, October 23rd were issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. The ex-dividend date was Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

Insiders Place Their Bets

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the transaction, the director directly owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This represents a 25.29% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 1.22% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several analysts recently issued reports on CVS shares. The Goldman Sachs Group started coverage on shares of CVS Health in a research note on Tuesday, October 14th. They set a “buy” rating and a $91.00 price objective for the company. Bernstein Bank cut their target price on CVS Health from $78.00 to $72.00 and set a “market perform” rating on the stock in a research report on Wednesday, July 16th. Truist Financial restated a “buy” rating and set a $95.00 price target (up from $92.00) on shares of CVS Health in a research report on Thursday, October 30th. Barclays lifted their target price on CVS Health from $80.00 to $87.00 and gave the company an “overweight” rating in a research report on Thursday, September 4th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of CVS Health in a research note on Wednesday. Two investment analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $88.82.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.